Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis. [PDF]
Sharma G, Dubey A, Nolkha N, Singh JA.
europepmc +1 more source
A single-centre experience of febuxostat as a second-line urate-lowering therapy. [PDF]
Ong SG, Ding HJ.
europepmc +1 more source
Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study [PDF]
core +1 more source
Association between hyperuricemia, gout, urate lowering therapy, and osteoarthritis
Junyu Zhu +5 more
openalex +1 more source
Depressive Symptoms and the Effectiveness of a Urate-Lowering Therapy in a Clinical Trial. [PDF]
Mrug S +6 more
europepmc +1 more source
Effectiveness of Urate-Lowering Therapy for Renal Function in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials. [PDF]
Liang X, Liu X, Li D, Qin W, Liu Y.
europepmc +1 more source
Urate-Lowering Therapy for the Management of Gout: A Summary of 2 Cochrane Reviews [PDF]
Alison S Kydd +6 more
openalex +1 more source
Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients. [PDF]
van de Laar CJ +5 more
europepmc +1 more source

